| Cash Flow | 2025-11-01 | 2025-08-02 |
|---|---|---|
| Revenue | 4,446,339 | 2,981,928 |
| Cost of sales | 2,722,037 | 1,826,641 |
| Advertising and marketing expenses | 111,430 | 73,367 |
| Stock compensation - general and administrative | 25,022 | 17,979 |
| Other general and administrative expenses | 1,499,273 | 1,004,560 |
| Interest income | 4,082 | 2,268 |
| Interest expense | 99,618 | 66,791 |
| Income tax benefit | -5,035 | 1,241 |
| Income from equity method investees | 13,565 | 8,694 |
| Net income (loss) | 11,641 | 2,311 |
| Depreciation and amortization | 148,466 | 98,649 |
| Amortization of debt discounts and issuance costs | 3,760 | 2,499 |
| Provision for deferred taxes | -50 | 1,113 |
| Equity-based compensation | 25,372 | 18,209 |
| Impairments, write-offs and losses on sale of fixed and other assets | 677 | 522 |
| Income from equity method investees | 13,565 | 8,694 |
| Amounts reclassified out of accumulated other comprehensive loss | 561 | 413 |
| Non-cash operating lease costs | 308,297 | 205,005 |
| Other non-operating loss (income) | 0 | 0 |
| Receivables | 2,709 | -5,783 |
| Merchandise inventories | -35,433 | -44,823 |
| Prepaid expenses and other assets | 2,437 | 9,487 |
| Accounts payable and book overdrafts | -63,121 | -69,691 |
| Accrued salaries and employee benefits | -46,238 | -26,729 |
| Accrued expenses and other liabilities | 30,028 | 14,508 |
| Operating lease liabilities | -273,942 | -206,414 |
| Other long-term liabilities | -523 | -1,556 |
| Net cash provided by operating activities | 160,528 | 70,438 |
| Cash paid for fixed assets | 89,960 | 60,516 |
| Cash paid for acquisitions, net of cash acquired | 0 | 0 |
| Cash paid for investment | 0 | - |
| Proceeds from investment | 0 | 0 |
| Proceeds from sale of assets | 2,541 | 2,425 |
| Cash received from partial surrender of officers' life insurance | 0 | 0 |
| Net cash used in investing activities | -87,419 | -58,091 |
| Borrowings under long-term debt agreements | 0 | 0 |
| Repayments of long-term debt | 0 | 0 |
| Debt refinancing costs | 0 | 0 |
| Payments for finance lease liabilities | 4,433 | 3,252 |
| Proceeds from employee stock purchase plan and stock option exercises | 2,738 | 1,998 |
| Tax withholdings on stock-based awards | 3,656 | 3,026 |
| Proceeds from issuance of common stock | 0 | 0 |
| Net cash used in financing activities | -5,351 | -4,280 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 67,758 | 8,067 |
| Cash and cash equivalents at beginning of period | 181,665 | - |
| Cash and cash equivalents at end of period | 249,423 | - |
Petco Health & Wellness Company, Inc. (WOOF)
Petco Health & Wellness Company, Inc. (WOOF)